Overview
Investors searching NEAR vs INJ usually want a clear market-cap and momentum snapshot. NEAR Protocol prints $1.70 (+1.50%) while Injective is at $4.98 (+1.20%), with volume edge currently on NEAR Protocol.
Quick winners
Full comparison
| Metric | NEAR | INJ |
|---|---|---|
| Price | $1.70 | $4.98 |
| Market Cap | $2.35B | $490.41M |
| FDV | — | — |
| Volume 24h | $12.95M | $2.75M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 39.00 | 99.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +6.14% | +5.97% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | NEAR | INJ |
|---|---|---|
| 1H | — | — |
| 24H | +1.50% | +1.20% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | NEAR | INJ |
|---|---|---|
| RSI | 37.84 | 49.29 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 0.10 | 0.29 |
| ADX | 13.80 | 12.19 |
| Support | 1.61 | 4.91 |
| Resistance | 1.88 | 5.07 |
| Trend | neutral | neutral |
| Momentum | — | — |
| Signal | neutral | neutral |
Automatic technical analysis
Relative technical health favors reading both charts side by side. AI scores (44.10 vs 47.20) summarize PEPS modules, but supports and resistances still decide invalidation.
Fundamentals
| Metric | NEAR | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | 103.00 | 0.00 |
| Github activity | 2,590.00 | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
NEAR Protocol
Injective
Pros and cons
Pros of NEAR Protocol
- Composite PEPS readings for NEAR Protocol can surface clearer module agreement during trend phases.
- Market-cap scale on NEAR Protocol may dampen some idiosyncratic shocks versus smaller peers.
- NEAR Protocol has an established coin page footprint on PEPS for continuous monitoring.
Cons of NEAR Protocol
- When dominance narratives fade, NEAR Protocol can lag hotter rotation names.
- Regulatory or macro headlines can hit NEAR Protocol harder simply because it is more visible.
- Indicator stacks on NEAR Protocol may stay stretched longer than expected in strong trends.
- Large-cap status for NEAR Protocol can mean slower percentage upside versus high-beta alternatives.
Pros of Injective
- Narrative optionality around Injective can reprice quickly when catalysts appear.
- Active volume bursts on INJ sometimes precede sharper tactical moves.
- PEPS tracking for Injective still includes AI score and level context for monitoring.
Cons of Injective
- Smaller book depth versus large caps can increase slippage for Injective.
- Higher volatility on INJ cuts both ways and demands stricter risk limits.
- Trend failures on Injective often travel faster than on more established assets.
Which looks stronger right now?
If you weight capitalization and liquidity, NEAR Protocol looks sturdier; if you weight 24h tape, NEAR Protocol is ahead. A balanced view treats both as incomplete signals.
AI summary
For readers asking which is “better”, the honest answer is conditional. NEAR Protocol and Injective solve overlapping but not identical market jobs. On-chain and developer fields, when available, add slower-moving context beneath the tape. Missing fundamentals should be treated as unknown, not as zeros. If your thesis is long-term adoption, weight fundamentals and liquidity; if tactical, weight trend/momentum — and always define invalidation.
FAQ
Which is better, NEAR Protocol or Injective?
“Better” depends on horizon and risk. NEAR Protocol leads on market cap today, while NEAR Protocol leads the 24h move — neither is a guarantee.
Which has more upside potential, NEAR or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both NEAR Protocol and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. NEAR Protocol currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is NEAR Protocol, but longer windows can disagree.